SARS-CoV-2 Lin. BA.4; Omicron Var. (USA/MD-HP30386/2022) Culture Fluid (Heat Inactivated) (1 mL)
- Volume: 1.0mL
- Units/Pack: 1
- Hazardous Information: Non-Infectious
- Storage Condition: -65°C or below
Description
SARS-Related Coronavirus 2 Lineage BA.4; Omicron Variant (Isolate: USA/MD-HP30386/2022) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/MD-HP30386/2022 was isolated from a human on April 9, 2022, in Maryland, USA.
Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV-19/USA/MD-HP30386/2022 is assigned lineage BA.4.1 (Pango v.4.1.1 PANGO-v1.12), Omicron (BA.4-like) (Scorpio) and GISAID clade GRA using the Phylogenetic Assignment of Named Global Outbreak lineages (PANGO) tool.1,2,3 The complete genome of SARS-CoV-2, isolate hCoV-19/USA/MD-HP30386/2022 has been sequenced (GISAID: EPI_ISL_12416220).
Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot.
Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.